These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 18603890

  • 1. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [Abstract] [Full Text] [Related]

  • 2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 3. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC, Lung FW, Chong MY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
    [Abstract] [Full Text] [Related]

  • 4. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL, González Pinto A, Eguiluz I, Fernández A.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996 Mar; 24(4):165-72. PubMed ID: 8984849
    [Abstract] [Full Text] [Related]

  • 5. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [Abstract] [Full Text] [Related]

  • 6. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 7. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 8. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
    Csernansky JG, Mahmoud R, Brenner R, Risperidone-USA-79 Study Group.
    N Engl J Med; 2002 Jan 03; 346(1):16-22. PubMed ID: 11777998
    [Abstract] [Full Text] [Related]

  • 9. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.
    Int J Neuropsychopharmacol; 2008 Nov 03; 11(7):985-97. PubMed ID: 18466670
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of risperidone in Asian patients with schizophrenia in Singapore.
    Chong SA, Yap HL, Low BL, Choo CH, Chan AO, Wong KE, Mahendran R, Chee KT.
    Singapore Med J; 1999 Jan 03; 40(1):41-3. PubMed ID: 10361485
    [Abstract] [Full Text] [Related]

  • 11. [Perospirone therapy in elderly patients with schizophrenia].
    Masui T, Honma H, Kondo C, Osawa T, Iwasaki S, Matsubara S.
    Seishin Shinkeigaku Zasshi; 2003 Jan 03; 105(10):1247-53. PubMed ID: 14679781
    [Abstract] [Full Text] [Related]

  • 12. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE, Dries PJ, Melman CT, Wapenaar RJ, Loonen AJ.
    J Psychopharmacol; 2005 Jan 03; 19(1):51-7. PubMed ID: 15671129
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Eerdekens M, Davidson M.
    Int J Geriatr Psychiatry; 2004 Sep 03; 19(9):898-905. PubMed ID: 15352149
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr 03; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [Abstract] [Full Text] [Related]

  • 15. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M, Chen H, Li LH, Wu R, Li Y, Liu L, Ye M, Huang J, Zhu S, Wang G, Zhang Q, Zheng H, Zhang L, Wang B, Zhou J, Zhao JP.
    Int Clin Psychopharmacol; 2012 Mar 03; 27(2):107-13. PubMed ID: 22233697
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A, Okamura T.
    Psychiatry Clin Neurosci; 2005 Oct 03; 59(5):556-62. PubMed ID: 16194258
    [Abstract] [Full Text] [Related]

  • 17. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.
    Encephale; 2007 Dec 03; 33(6):973-81. PubMed ID: 18789790
    [Abstract] [Full Text] [Related]

  • 18. Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia.
    Cavallaro R, Mistretta P, Cocchi F, Manzato M, Smeraldi E.
    Hum Psychopharmacol; 2001 Aug 03; 16(6):439-448. PubMed ID: 12404552
    [Abstract] [Full Text] [Related]

  • 19. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R, Clozapine and Risperidone Enhancement (CARE) Study Group.
    N Engl J Med; 2006 Feb 02; 354(5):472-82. PubMed ID: 16452559
    [Abstract] [Full Text] [Related]

  • 20. Negative symptoms in schizophrenia: assessment of the effect of risperidone.
    Schooler NR.
    J Clin Psychiatry; 1994 May 02; 55 Suppl():22-8. PubMed ID: 7520905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.